Atheroma: Links with antiphospholipid antibodies, Hughes syndrome and lupus

D. Harats, J. George, Y. Levy, M. A. Khamashta, G. R.V. Hughes, Y. Shoenfeld

Research output: Contribution to journalShort surveypeer-review


Antiphospholipid antibodies (aPL) are found in a variety of autoimmune diseases, and are thought to predispose to arterial and venous thrombosis. These antibodies, when investigated in different assays in vitro, activate endothelial cells and promote uptake of modified LDL to macrophages. These observations suggest that aPL can contribute to atheroma development by targeting some of the sequential steps that constitute early atherogenesis. If substantiated by large-scale clinical trials, the pro-atherogenic properties of aPL may merit screening and intervention programs in selected populations.

Original languageEnglish
Pages (from-to)57-59
Number of pages3
JournalQJM - Monthly Journal of the Association of Physicians
Issue number1
StatePublished - Jan 1999


Dive into the research topics of 'Atheroma: Links with antiphospholipid antibodies, Hughes syndrome and lupus'. Together they form a unique fingerprint.

Cite this